Prudential Financial’s Kite Pharma, Inc. KITE Stock Holding History

Prudential Financial’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,410	Closed	-$973K	–	2404
2017 Q3	$973K	Buy	5,410 +410	+8%	+$57.1K	﹤0.01%	1843
2017 Q2	$518K	Buy	5,000 +1,040	+26%	+$84.9K	﹤0.01%	2020
2017 Q1	$311K	Sell	3,960 -50,980	-93%	-$3.15M	﹤0.01%	2130
2016 Q4	$2.46M	Buy	54,940 +47,866	+677%	+$2.35M	﹤0.01%	1438
2016 Q3	$395K	Buy	7,074 +1,671	+31%	+$93.1K	﹤0.01%	2062
2016 Q2	$271K	Buy	+5,403	New	+$265K	﹤0.01%	2136

Prudential Financial's KITE Position: Q4 2017 in Review

Prudential Financial sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 5,410 shares — an estimated $973K sold.

Prudential Financial first reported a position in KITE in Q2 2016 and held it in 6 quarters. The position peaked at $2.46M in Q4 2016. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Prudential Financial reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Prudential Financial sold 5,410 Kite Pharma, Inc. shares in Q4 2017, an estimated $973K.
Prudential Financial first reported a position in Kite Pharma, Inc. in Q2 2016 and held it in 6 quarters.
Prudential Financial's Kite Pharma, Inc. position peaked at $2.46M in Q4 2016.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Prudential Financial's 13F filing for Q4 2017, filed 13 Feb 2018.